Added to YB: 2024-06-04
Pitch date: 2024-06-01
MEDP [bullish]
Medpace Holdings, Inc.
+26.73%
current return
Author Info
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$391.39
Price Target
462.50 (-7%)
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Medpace Holdings, Inc. - $MEDP
MEDP: CRO leader w/ 29.9% 5yr FCF/share CAGR. 47.4% 5yr stock CAGR. Bullish on '24 biotech funding recovery. Competitive edge vs peers. Founder-led, CEO owns 17% but sold 15% in '24. 22%+ rev from top 5 clients. 21%+ backlog & new biz CAGR. Risks: Competition, regulations, macro. $463 PT, 18% upside on 13% CAGR DCF. Caution: Insider selling may signal overvaluation.
Read full article (7 min)